Trial Profile
A Compassionate Use Study of Methylnaltrexone in Patients With Opioid-Induced Side Effects
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Sep 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Expanded access; Therapeutic Use
- Sponsors Progenics Pharmaceuticals
- 17 Jul 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 10 Jun 2011 New trial record